Remedy Plan Therapeutics To Unveil Phase 1 NAMPT Inhibitor RPT1G
04 Dec 2025 //
GLOBENEWSWIRE
Remedy Plan Therapeutics Progresses RPT1G For Myeloid Cancer
12 Nov 2025 //
GLOBENEWSWIRE
Remedy Plan Raises $18M to Advance RPT1G into Phase 1/2 Trial
13 May 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support